Skip to content

ENGN

enGene Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · CA

$1.58
−5.39%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
—
P/S forward
16.90x

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
0.46x
Price / sales
—
Price / cash flow
-1.02x

Enterprise value

Enterprise value
-$127.2M
EV / sales
—
EV / EBITDA
0.96x
EV / EBIT
27.15x
Market cap
$105.9M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jul 1, 2026